Can-Fite BioPharma CANF
NYSE CANF
$2.21 +0.03 (+1.61%)
As of: Sep 30, 2026 · 3:58 PM EDT

Can-Fite BioPharma (CANF) Receivables - Other (2013 - 2022)

Updated

Can-Fite BioPharma's Receivables - Other was $1.17 million in Q4 2022, up 25.9% from $929,000 a year earlier.

Analysis

Can-Fite BioPharma (CANF) Receivables - Other (2013 - 2022) Analysis & Trends

From Q3 2013 onward, Can-Fite BioPharma has reported Receivables - Other for 6 quarters.

  • Receivables - Other shows a three-year compound annual growth rate of -35.6% (FY2019 to FY2022).
  • In earlier years, Receivables - Other was $929,000 in FY2021 (-12.1%), $1.06 million in FY2020 (-75.9%) and $4.38 million in FY2019.
  • The Q4 2022 figure marks the highest quarterly Receivables - Other since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.17 Mn
Dec 31, 2021 929,000.00
Dec 31, 2020 1.06 Mn
Dec 31, 2019 4.38 Mn
Sep 30, 2019 1.75 Mn
Sep 30, 2013 18,000.00
API Access

Can-Fite BioPharma Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CANF&period=max&api_key=YOUR_API_KEY